Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sygnature Discovery has contributed to the advancement of over 56 pre-clinical compounds and more than 34 clinical compounds for its clients. Their scientists have been named on over 200 customer patent applications. Since its founding, at least sixteen client compounds have advanced into the clinic with their support, spanning Phases I–III trials. The company itself does not own or commercialize drugs but enables success for pharma/biotech partners through integrated drug discovery services
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sygnature Discovery.